Literature DB >> 7909766

Pap smear screening and changes in cervical cancer mortality in Sweden.

C G Mählck1, H Jonsson, P Lenner.   

Abstract

OBJECTIVES: Age-adjusted incidence of cervical carcinoma has fallen dramatically in Sweden in recent decades. This investigation is an attempt to evaluate the effectiveness of the gynecologic Pap smear screening program in terms of reduction of mortality from cervical cancer.
METHODS: Cervical cancer mortality trends in relation to age, calendar period, county and degree of screening activities in the population were analyzed. Multiplicative Poisson regression models were utilized. The reduction of mortality was attributed to the activities of cervical screening.
RESULTS: The analysis gave a calculated 53% reduction in cervical cancer mortality (95% confidence limits 23-72%), attributable to screening.
CONCLUSIONS: The study supports the hypothesis that gynecological Pap smear screening has had an important impact on the reduction in cervical cancer mortality.

Entities:  

Mesh:

Year:  1994        PMID: 7909766     DOI: 10.1016/0020-7292(94)90177-5

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  16 in total

1.  The screening history of women with cervical cancer in the Rotterdam area.

Authors:  F A Kreuger; H Beerman
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 2.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

3.  Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya.

Authors:  E Were; Z Nyaberi; N Buziba
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

4.  Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.

Authors:  Zhenjie Yang; Juan Liu; Qing Wang
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

5.  Generational risks for cancers not related to tobacco, screening, or treatment in the United States.

Authors:  Yueh-Ying Han; Devra L Davis; Joel L Weissfeld; Gregg E Dinse
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

6.  Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda.

Authors:  Twaha Mutyaba; Francis A Mmiro; Elisabete Weiderpass
Journal:  BMC Med Educ       Date:  2006-03-01       Impact factor: 2.463

7.  High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study.

Authors:  Reinhard Höpfl; Anton Petter; Petra Thaler; Mario Sarcletti; Andreas Widschwendter; Robert Zangerle
Journal:  BMC Infect Dis       Date:  2003-04-30       Impact factor: 3.090

8.  The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.

Authors:  S Andersson; E Rylander; A Strand; J Sällström; E Wilander
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

9.  Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN).

Authors:  S Andersson; H Safari; M Mints; I Lewensohn-Fuchs; U Gyllensten; B Johansson
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

10.  Influences on uptake of reproductive health services in Nsangi community of Uganda and their implications for cervical cancer screening.

Authors:  Twaha Mutyaba; Elisabeth Faxelid; Florence Mirembe; Elisabete Weiderpass
Journal:  Reprod Health       Date:  2007-06-26       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.